Ajanta Pharma releases earnings call transcript for April 30th

Ajanta Pharma announced today the release of the written transcript of its earnings call conducted on April 30, 2025, at 4:30 p.m. The release, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, provides stakeholders with detailed insights into the company's financial performance and strategic discussions. The transcript is accessible on Ajanta Pharma’s website at https://ajantapharma.com//images/Earnings-Call-Transcript-Q4-(Jan-Mar)-2024-25.pdf. This announcement informs shareholders and the broader investment community, ensuring transparency and facilitating informed decision-making.